# Dexlevo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dexlevo

- Industry: Healthcare
- Headquarters: Seoul, South Korea
- Website: www.dexlevo.com
- Total disclosed funding: $4.9M
- Latest round: Series B (Aug 24, 2018)
- Investors on record: 2

## About

Dexlevo specializes in developing innovative medical aesthetic products utilizing advanced polymer technology to meet aesthetic market demands, enhancing drug delivery systems for optimal effectiveness.Dexlevo, founded in 2013 and headquartered in Seoul, South Korea, focuses on medical aesthetics. The company has made strategic pivots, most notably raising KRW 26 billion in a Pre-IPO round in November 2021, led by Hyundai Venture Investment Corporation, Magna Investments, Shinhan Capital, and Smilegate Investment. Total funding raised to date amounts to KRW 26 billion. The company's CEO is Jaewon Yu.DEXLEVO INC. specializes in the research and manufacturing of medical aesthetic products, primarily focusing on advanced polymer technology. Their core offerings include the Collagenesis-Enabled Solubilized Active Biodegradable Polymer Smart Drug Delivery System, which innovatively addresses unmet needs in the aesthetic market by providing effective delivery mechanisms for active ingredients. This product targets both medical professionals and end users seeking advanced aesthetic treatments, ensuring optimal results through a smart delivery system that enhances the efficacy of pharmaceuticals. DEXLEVO's product line is available in various international markets, extending its reach to regions such as North America, Europe, and parts of Asia, catering to a diverse clientele composed of aesthetic clinics, healthcare providers, and cosmetic brands.Revenue generation for DEXLEVO INC. is predominantly structured around B2B transactions, where they collaborate directly with healthcare providers and aesthetic clinics. In 2018, the company reported a revenue of KRW 610,488 and an EBITDA of KRW -482,218. They likely engage in agreements that include wholesale partnerships, allowing these clients to distribute DEXLEVO's products within their own networks, fostering long-term relationships with clients.Dexlevo plans to utilize funds from its recent KRW 26 billion Pre-IPO funding round to establish a new cGMP-grade production facility in Songdo and enhance marketing efforts for its flagship product. The company aims to launch new products in the upcoming years, targeting specific markets for expansion, particularly in North America and Europe, by 2023.

## Funding rounds

- Series B, Aug 24, 2018, $4.9M — Hyundai Venture Investment, Magna Investment

## Investors

- Hyundai Venture Investment (https://capitalatlas.ai/funds/hyundai-venture-investment) — Series B
- Magna Investment (https://capitalatlas.ai/funds/magna-investment) — Series B